According to the National Medical Commission (NMC), 972 students have gone overseas to study medicine without acquiring an eligibility certificate. If an applicant earns qualifying without getting an eligibility certificate, he or she will be unable to take the screening exam.
The commission has given all such students 10 days to submit their applications via the NMC eligibility portal.
Furthermore, the notice from NMC stated that the requirement of taking the certificate before proceeding abroad has been dispensed with effect from the declaration of the result of NEET-UG 2019 via public notice dated April 5, 2019 and that qualifying NEET-UG Exam has been made mandatory and shall be deemed to be treated as an eligibility certificate for Indian/OCI citizen intending to take admission in MBBS or equivalent medical course in any foreign m
“It has come to our attention that applicants whose names appear in Annexure-I have traveled abroad without obtaining an Eligibility Certificate.” As a result, the Board has decided to provide all such applicants (Annexure-I) 10 days to submit their applications via the NMC eligibility portal. If the applicants whose names appear in Annexure-I fail to meet the requirement or do not submit their applications within 10 days of the date of publication of this notice, their applications will be summarily rejected,” the notification said.
To be sure, NMC has evaluated all of the applications that were submitted. Following a review, it detected several problems and issued a notice.
In 2023, the healthcare industry in India will see an unprecedented spike in investment, with over $4 billion in inflows. Private equity (PE) investments increased by 9-10%, compared to 2% before to COVID-19 and 5% last year.
With almost 20 private equity investments totaling $3.8 billion, hospitals dominated the investment environment, including healthcare technology, medical equipment, and diagnostics. Temasek and Blackstone emerged as dominant owners of extensive hospital networks, acquiring 15,000 hospital beds throughout the country.
Looking forward to 2024, healthcare remains a primary concern for Indian private equity businesses. Expect ongoing momentum in multi-specialty, regional, and single-specialty hospitals, with transaction volumes ranging from 500 to 1,000 crore. While the number of acquisitions may be reduced somewhat owing to fewer chances, Blackstone and other PE firms are expected to put up comparable platforms, indicating higher deal activity.
